Article
Impact of APOE ε4 and ε2 on plasma neurofilament light chain and cognition in autosomal dominant Alzheimer's disease.
Alzheimer's research & therapy - 1 Oct 2024
Langella Stephanie, Bonta Kyra, Chen Yinghua, Su Yi, Vasquez Daniel, Aguillon David, Acosta-Baena Natalia, Baena Ana Y, Garcia-Ospina Gloria, Giraldo-Chica Margarita, Tirado Victoria, Muñoz Claudia, Ríos-Romenets Silvia, Guzman-Martínez Claudia, Pruzin Jeremy J, Ghisays Valentina, Arboleda-Velasquez Joseph F, Kosik Kenneth S, Tariot Pierre N, Reiman Eric M, Lopera Francisco, Quiroz Yakeel T
Abstract excerpt
BACKGROUND: Apolipoprotein E (APOE) genotypes have been suggested to influence cognitive impairment and clinical onset in presenilin-1 (PSEN1) E280A carriers for autosomal dominant Alzheimer's disease (ADAD). Less is known about their impact on the trajectory of biomarker changes. Neurofilament light chain (NfL), a marker of neurodegeneration, begins to accumulate in plasma about 20 years prior to the clinical...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
